NEW YORK, Aug. 10, 2017 /PRNewswire/ -- Instinet, LLC today announced the appointment of Christopher Eberle as Senior Equity Research Analyst covering the Software sector, as part of its continuing strategy to grow its U.S. Equity Research offering.
Based in New York, Christopher joins Instinet from Folger Hill Asset Management, where he was a portfolio manager overseeing all investments for the firm's Global Technology Funds. Prior to that, he was Co-Manager and Senior Analyst for CDP Global Asset Management with a focus on TMT. He previously held roles in equity research at ThinkEquity, LLC and Oppenheimer & Co.
"Christopher's buy-side experience will offer a valuable perspective as we continue to focus on providing clients with an insightful, boutique-style research offering. Christopher's contribution will give us the opportunity to further expand the coverage footprint of what is already a strong, alpha-generating platform in the Americas," said Mark Govoni, President, Instinet, LLC.
On November 14, 2016, Instinet, LLC integrated the U.S. Equity Research and Research Sales team from Nomura Securities International into its market-leading cash equities platform, creating a multi-sector, boutique research offering. Instinet's and Nomura's execution clients continue to have seamless access to both Instinet's U.S. and Nomura's research offerings globally.
As the equity execution services arm of the Nomura Group, Instinet Incorporated's subsidiaries provide independent, agency-model brokerage services to clients throughout the world. Through its advanced suite of electronic trading tools, experienced high-touch trading group and unparalleled access to insightful content and liquidity, Instinet helps institutions lower overall trading costs and ultimately improve investment performance. Over the course of its 45+ year history, Instinet has introduced a range of now industry-standard trading technologies as well as the world's first major electronic trading venue, one of the first U.S. ECNs and the Chi-X businesses. For more information, please visit instinet.com.